April 6th 2024
Investigators presented research on the pre-treatment outcomes during the 2024 ASCRS meeting
Application of Recent Data in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Managed Care Insights and Strategies
View More
(CME Credit) Community Practice Connection™: Paradigm Shifts in Presbyopia – Understanding Advances in Topical Treatment Innovations
View More
(COPE Credit) Analyzing Novel Tear Stimulating Treatments for Special Populations in Dry Eye Disease
View More
(CME/CNE Credit) Community Practice Connections™: Restoring the Surface Impact of Preservatives and Novel Formulations in First Line Treatments for Dry Eye Disease
View More
(CME/CNE Credit) Analyzing Novel Tear Stimulating Treatments for Special Populations in Dry Eye Disease
View More
(CME Credit) Community Practice Connections™: Improving Management of MGD-Associated Dry Eye Disease—A Look to the Future of Treatment
View More
(COPE Credit) Community Practice Connections™: Improving Management of MGD-Associated Dry Eye Disease—A Look to the Future of Treatment
View More
(COPE Credit) Community Practice Connections™: Restoring the Surface – Impact of Preservatives and Novel Formulations in First Line Treatments for Dry Eye Disease
View More
18th Annual Controversies in Modern Eye Care
May 4, 2024
Register Now!
Headed to ARVO? You’re invited to dinner COPE CE/CME. Or join virtually!
May 6 & 7, 2024
Register Now!
(COPE Credit) Community Practice Connection™: Paradigm Shifts in Presbyopia – Understanding Advances in Topical Treatment Innovations
View More
(CME Credit) Learning About the Lid – Optimizing Recognition, Diagnosis, and Treatment of Demodex Blepharitis & Blepharoptosis
View More
2nd Annual IKA Keratoconus Symposium: Front to Back and Everything in Between
May 18-19, 2024
Register Now!
(COPE Credit) Learning About the Lid – Optimizing Recognition, Diagnosis, and Treatment of Demodex Blepharitis & Blepharoptosis
View More
(CME Credit) Virtual Case Studies™ in Cataract Surgery: Selecting Surgical Techniques and Preventing Intra-Operative Complications
View More
(COPE Credit) Clinical Crossroads: Navigating Neurotrophic Keratitis – The Importance of Avoiding Pitfalls and Ensuring Early Intervention
View More
Neurotrophic Keratitis Management: How Early Intervention Can Make a Difference
View More
(CME Credit) Clinical Crossroads: Navigating Neurotrophic Keratitis – The Importance of Avoiding Pitfalls and Ensuring Early Intervention
View More
17th Annual Controversies in Modern Eye Care
View More
Thyroid Eye Disease: The Masquerading Eye Disorder—A Guide to Collaborative Care and Accurate Diagnosis
View More
(COPE Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME
View More
(CME Credit) Community Practice Connections™: Multidisciplinary Perspectives on Saving Sight—The Expanding Role of the Optometrist in Retinal Disease Care
View More
(COPE Credit) Community Practice Connections™: Advances in Geographic Atrophy – Optimizing Diagnosis, Monitoring Progression, and Increasing Communication with Transformative Treatment on the Horizon
View More
(COPE Credit) Community Practice Connections™: Multidisciplinary Perspectives on Saving Sight—The Expanding Role of the Optometrist in Retinal Disease Care
View More
(CME Credit) Community Practice Connections™: Advances in Geographic Atrophy – Optimizing Diagnosis, Monitoring Progression, and Increasing Communication with Transformative Treatment on the Horizon
View More
(CME Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME
View More
What’s New in MGD Beyond Heating and Squeezing?
View More
The Ins and Outs of Lubricating Eye Drops
View More
Addressing Healthcare Inequities™ in Glaucoma Management – Understanding Challenges in Segmented Patient Populations (CME Track)
View More
Community Practice Connections™: Expert Perspectives in Diabetic Macular Edema – Considering Pathogenesis & Inflammation in Treatment Selection
View More
Endophthalmitis: how should we be preventing it?
November 1st 2006At the ESCRS congress in September, Peter Barry presented the full ESCRS endophthalmitis study results and controversially stated that, not only is the incidence of endophthalmitis higher than reported in the literature, but the risk of infection is further increased by clear corneal incisions and the use of silicon IOLs.
How to effectively correct residual ametropias
November 1st 2006Ophthalmologists have been seeking to achieve the same quality and surgical success for high ametropia as has already been achieved for moderate ametropias. The analysis of refractive outcomes of procedures such as the Ferrara Ring implantation to correct early keratoconus, thermokeratoplasty to correct hypermetropia and corneal transplantation frequently reveals the presence of a residual ametropia that results in low or moderate visual acuity. It is our belief that the Artisan phakic intraocular lens (IOL) (Advanced Medical Optics) could go some way to adressing this issue. Hence, after mastering the surgical procedures involved for the implantation of the phakic IOL and its indication as an option for refractive surgery, we looked to assess the benefits of secondary lens implantation in the correction of residual ametropia and the impact it has on patient quality of life.
Exchanging lenses for clear vision
October 1st 2006Refractive surgery dates back to the 19th century, when L.J. Lans demonstrated the effect of applying heat to the cornea to treat astigmatism. Once considered only by the courageous, refractive surgery has now become an everyday alternative form of visual correction, made possible by improvements in our understanding of corneal anatomy and physiology and the development of remarkable new tools.
Hyperopic presbyopia: a new term for an old problem and its modern solution
October 1st 2006The development of presbyopia in hyperopic people aged between 45 and 65 is a serious refractive problem that, until recently, has had no practical solution. Individuals in this category are not usually considered to be "patients" but, nevertheless, face real problems with their everyday near and distance sight. We call this problem "hyperopic presbyopia".
STAR S4 IR excimer laser with CustomVue
September 1st 2006The May 2005 acquisition of VISX saw AMO inherit a large installed base of refractive surgery technologies, which not only complemented its refractive IOL portfolio, but also transformed AMO into the world's leading refractive surgical company.
Wavefront technologies: Helping you to decide what's best for your patient
September 1st 2006Wavefront analysis of the human eye is based on an optical theory that was first developed in astronomy more than 100 years ago, with roots that date back almost 400 years. Astronomers used the technology to reduce higher order aberrations (HOAs) induced by the earth's atmosphere. Recognising the potential of this analysis in ocular refractive surgery, manufacturers have recently introduced wavefront technology into several major laser systems in order to improve treatment outcomes and address HOAs within the visual system.
Visual correction in childhood aphakia
September 1st 2006Early surgical intervention and adequate orthoptic therapy are important when dealing with children who have undergone cataract surgery. A pseudophakic implant represents an effective solution for the management of aphakic children; a multifocal IOL can provide additional correction, without hindering quality of vision. Here, Klaus Weber, MD provides a brief overview of the incidence, causes and management of childhood cataract, and recommends potential avenues of treatment for the visual rehabilitation of paediatric patients with aphakia.
22 gauge bimanual phaco: the final frontier?
September 1st 2006It ensures faster rehabilitation of patients operated on using 22 gauge compared with conventional 2.8 mm coaxial phaco, probably because of the reduction in postoperative trauma during emulsification of the crystalline lens in a closed system with narrow incisions
Multifocal IOLs: The mix and match approach
September 1st 2006The mixing and matching of refractive and diffractive multifocal intraocular lenses (MIOLs) to enhance vision in cataract patients is not a new concept. In fact, the theory was first pioneered and realised in 2000 by Uzeyir G?nenc, MD of Dokuz Eyl?l University, Izmir, Turkey, who went on to present his first set of results at the 2003 congress of the ASCRS. So why is it that, back then, nobody really paid attention to this technique? The answer is simple; the idea at that time seemed quite bizarre and was something that many surgeons would never consider performing in their own practice. Three years on and armed with five-year data, the global ophthalmic community is now starting to pay attention.
The femtosecond laser in everyday clinical use
July 1st 2006As a result of our excellent postoperative patient data in a variety of applications, we will continue to use the femtosecond laser technology in our practice. It supports our procedures with great precision and safety, it is easy to use and enables us to set new standards in our surgeries
Phakic IOLs: what could go wrong?
July 1st 2006The popularity of phakic IOLs in both cataract and refractive surgery has soared in recent years with lens manufacturers all joining the race to develop better lenses with improved outcomes and fewer complications. Although phakic IOLs are considered the ideal tools for the correction of high ametropias, because of their excellent accuracy and predictability, stability of refraction from day one and independence of tissue healing, they have, unfortunately, been marred by reports of certain complications throughout their development history. These complications include corneal decompensation, chronic inflammation, iris atrophy (pupil distortion), cataract and glaucoma. Here, Ant?nio Marinho, MD, PhD discusses the influence of phakic IOLs on cataract and glaucoma development.
The post-LASIK cornea: what's the damage?
July 1st 2006Globally, LASIK is a very popular refractive procedure, which provides excellent visual acuity and quality of vision in low to moderate myopia and hyperopia.1 In the mid-nineties, however, LASIK was performed even in extreme myopic errors (up to 23D) or in corneas that were too thin with or without Forme Fruste Keratoconus (FFKC).